ID

14484

Description

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00628758

Lien

https://clinicaltrials.gov/show/NCT00628758

Mots-clés

Versions (1)
  1. 18/04/2016 18/04/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

18 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT00628758

Anglais

Eligibility Asthma NCT00628758

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00628758
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed informed consent form. if the patient cannot read and write, verbal consent from the patient is required.
Description

informed consent form

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
ability to read and write in turkish
Description

turkish literacy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0023864
UMLS CUI [1,2]
C0041402
female or male outpatients aged 18 years
Description

outpatients aged 18 years

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0029921
minimum of 3 months history of asthma, diagnosed according to the american thoracic society (ats) definition
Description

history of asthma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0004096
UMLS CUI [1,3]
C0040223
prescribed inhaled glucocorticosteroid (gcs) at a dose of 320mg/day and within the approved label for the relevant drug during the last 3 months prior to visit 1
Description

ics

Type de données

boolean

Alias
UMLS CUI [1,1]
C3248292
UMLS CUI [1,2]
C0040223
either: daily maintenance treatment with both inhaled gcs and long-acting b2-agonist (laba) or daily treatment with inhaled gcs alone (i.e. without laba); and a history of suboptimal asthma control the month prior to enrollment as judged by the investigator; and use of 3 peak expiratory flow inhalations ofas needed medication for symptom relief during the last 7 days before enrollment
Description

asthma treatment

Type de données

boolean

Alias
UMLS CUI [1]
C2065041
UMLS CUI [2]
C0040223
UMLS CUI [3]
C1373132
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with symbicort single inhaler therapy
Description

symbicort

Type de données

boolean

Alias
UMLS CUI [1,1]
C1121854
UMLS CUI [1,2]
C1514463
use of any b-blocking agent, including eye drops
Description

adrenergic beta-antagonists

Type de données

boolean

Alias
UMLS CUI [1]
C0001645
use of oral gcs as maintenance treatment
Description

oral corticosteroid

Type de données

boolean

Alias
UMLS CUI [1]
C0001617
known or suspected hypersensitivity to study therapy or excipients
Description

hypersensitivity to study therapy or excipients

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0304229
a history of smoking 10 pack years
Description

smoking history

Type de données

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
pregnancy, breast-feeding or planned pregnancy during the study. fertile women not using acceptable contraceptive measures, as judged by the investigator
Description

pregnancy lactation intention to become pregnant

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C3831118
UMLS CUI [3]
C0700589
UMLS CUI [4]
C0006147
UMLS CUI [5,1]
C0032961
UMLS CUI [5,2]
C1283828
any significant disease or disorder, which, in the opinion of the investigator, may put the patient at risk because of participating in the study
Description

comorbidity limiting participation

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
Retour au début de la page

Similar models

Eligibility Asthma NCT00628758

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00628758
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
informed consent form
Item
signed informed consent form. if the patient cannot read and write, verbal consent from the patient is required.
boolean
C0021430 (UMLS CUI [1])
turkish literacy
Item
ability to read and write in turkish
boolean
C0023864 (UMLS CUI [1,1])
C0041402 (UMLS CUI [1,2])
outpatients aged 18 years
Item
female or male outpatients aged 18 years
boolean
C0001779 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
history of asthma
Item
minimum of 3 months history of asthma, diagnosed according to the american thoracic society (ats) definition
boolean
C0262926 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
ics
Item
prescribed inhaled glucocorticosteroid (gcs) at a dose of 320mg/day and within the approved label for the relevant drug during the last 3 months prior to visit 1
boolean
C3248292 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
asthma treatment
Item
either: daily maintenance treatment with both inhaled gcs and long-acting b2-agonist (laba) or daily treatment with inhaled gcs alone (i.e. without laba); and a history of suboptimal asthma control the month prior to enrollment as judged by the investigator; and use of 3 peak expiratory flow inhalations ofas needed medication for symptom relief during the last 7 days before enrollment
boolean
C2065041 (UMLS CUI [1])
C0040223 (UMLS CUI [2])
C1373132 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
symbicort
Item
previous treatment with symbicort single inhaler therapy
boolean
C1121854 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
adrenergic beta-antagonists
Item
use of any b-blocking agent, including eye drops
boolean
C0001645 (UMLS CUI [1])
oral corticosteroid
Item
use of oral gcs as maintenance treatment
boolean
C0001617 (UMLS CUI [1])
hypersensitivity to study therapy or excipients
Item
known or suspected hypersensitivity to study therapy or excipients
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
smoking history
Item
a history of smoking 10 pack years
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
pregnancy lactation intention to become pregnant
Item
pregnancy, breast-feeding or planned pregnancy during the study. fertile women not using acceptable contraceptive measures, as judged by the investigator
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C0032961 (UMLS CUI [5,1])
C1283828 (UMLS CUI [5,2])
comorbidity limiting participation
Item
any significant disease or disorder, which, in the opinion of the investigator, may put the patient at risk because of participating in the study
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial